The gene therapy landscape is rapidly growing and thus the opportunity for service providers specialising in gene therapy analytics is unprecedented.
Through research with the leading drug developers in the field, it’s clear that capacity is a huge challenge for gene therapy pharma and biotech companies, and further to that, the capacity of the service providers available to them. This is a major bottleneck for the field, with high pressured timelines in the race to deliver safe and effective gene therapy products to patients in need.
If you are a contract service or technology provider with the analytical experience and specific technologies to meet this exploding markets’ demands, then Gene Therapy Analytical Development Europe will provide a platform for you to showcase your solutions to a niche audience of analytical experts from the leading gene therapy developers.
Get in touch to find out more about the partnership opportunities available.